Por: The Atlantic Health August 26, 2023
Doctors are trying out a simple blood test to screen for some common pregnancy complications.GettyAugust 26, 2023, 8 AM ETThis article was originally published by .For expectant parents, pregnancy can be a time filled with joyful anticipation: hearing the beating of a tiny heart, watching the fetus wiggling through the black-and-white blur of an ultrasound, feeling the jostling of a little being in the belly as it swells.But for many, pregnancy... + full article
The Hill USA Health April 08, 2023
The Food and Drug Administration (FDA) is pulling its approval of the only drug on the market for reducing the risk of preterm birth in pregnant women, citing a lack of effectiveness demonstrated by the treatment. The FDA approved Makena in 2011 under its accelerated approval... + más
US gets D+ grade for rising preterm birth rates, new report finds | CNN
FDA panel recommends pulling preterm birth drug from the market | The Boston Globe
The New York Times USA Health March 08, 2023
The company that makes Makena, the only drug aimed at preventing preterm birth, announced on Tuesday that it was voluntarily pulling the medication off the market after advisers for the Food and Drug Administration concluded that the treatment did not help pregnant women at... + más
CNN USA Health November 15, 2022
CNN — The rate of premature birth in the United States is climbing, according to the infant and maternal health nonprofit March of Dimes. On Tuesday, the organization released its , which involves a newly updated calculation system. Taking an in-depth look at premature... + más
F.D.A. Panel Recommends Pulling Preterm Birth Drug From the Market | The New York Times
Time USA Life October 28, 2022
Every day, as I rush to preterm deliveries on the labor floor of my safety-net hospital and work beside incubators and clear plastic hospital bassinets, one of my patients’ mothers confides to me her belief that if she had only done that one thing differently during pregnancy,... + más
The New York Times USA Health October 20, 2022
A Food and Drug Administration advisory committee on Wednesday recommended removing the drug Makena from the market, after years of study showed the fast-tracked drug had failed to prevent preterm births.Makena has been in use for 11 years, and the panel’s vote was widely of... + más
FDA panel recommends revoking the approval of controversial drug intended to prevent premature birth | CNBC
The Boston Globe USA Nation October 20, 2022
A Food and Drug Administration advisory committee on Wednesday recommended removing the drug Makena from the market, after years of study showed the fast-tracked drug had failed to prevent preterm birth.Makena has been in use for 11 years, and the panel’s vote was widely... + más
CNBC USA Health October 19, 2022
An advisory panel to the Food and Drug Administration voted Wednesday to take a drug intended to prevent premature births off the market, saying that it remains doubtful that the drug works.The recommendation, in a 14-1 vote, from the agency's Obstetrics, Reproductive and... + más
FDA panel backs removal of unproven pregnancy drug | WPLG Local 10
ALS drug wins FDA approval despite questionable data | ABC News
About iurex | Privacy Policy | Disclaimer |